STSA

Satsuma Pharmaceuticals, Inc. Common Stock
STSA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

STSA was delisted on the 7th of June, 2023.

Back to rankings

30 hedge funds and large institutions have $202M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 30 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$70.3M
2
+$35.8M
3
+$28.3M
4
Citadel Advisors
Citadel Advisors
Florida
+$14.4M
5
CC
Caxton Corporation
New Jersey
+$13.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$70.3M
2
$35.8M
3
$28.3M
4
$14.4M
5
$13.1M
6
$12.9M
7
$9.16M
8
$6.38M
9
$4.63M
10
$1.5M
11
$938K
12
$900K
13
$533K
14
$526K
15
$525K
16
$501K
17
$413K
18
$225K
19
$212K
20
$150K
21
$125K
22
$104K
23
$34K
24
$28K
25
$22K
1
2